Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2013-02-05

Clinical Trial Update: Comparison of Glargine and Oral Antidiabetic Drugs (OADs) in Newly Diagnosed Type 2 Diabetes [NA]

View source ↗

Summary

A completed clinical trial comparing insulin glargine with oral antidiabetic drugs in newly diagnosed type 2 diabetes.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Insulin Glargine (insulin glargine)
  • oral antidiabetic drugs (OADs)

Snippet

Sponsor: Chongqing Medical University | Conditions: Diabetes | NA | Status: COMPLETED